This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boyd, B Articles by Gariepy, J Search for Related Content PubMed PubMed Citation Articles by Boyd, B Articles by Gariepy, J

 Previous Article  |  Next Article 

Infect Immun. 1991 March; 59(3): 750-757

Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin.

Department of Medical Biophysics, University of Toronto, Ontario, Canada.

ABSTRACT

The B subunit of Shiga toxin and Shiga-like toxin (SLT-1) and its fragments are potentially immunogenic and may generate protective humoral responses against the action of these toxins. We have analyzed the antibody response of rabbits immunized with pure B subunit of SLT-1 or synthetic fragments of the subunit. The immune response to the native B subunit was found to be largely directed at conformational epitopes. More importantly, rabbits immunized with the B subunit were protected from a lethal challenge with SLT-1, indicating that the B subunit represents an excellent vaccine candidate to counter the effects of Shiga toxin and SLT-1 in humans. Polyclonal antibodies against a synthetic peptide corresponding to residues 28 to 40 of the B subunit neutralized the cytotoxicity of SLT-1 towards Vero cells. This region is thus exposed in the native state of the B subunit. The sequence specificity of other antipeptide antisera also provides clues to the state of folding and assembly of the B subunit. Antisera to synthetic peptides representing the N- and C-terminal regions of the SLT-1 B subunit did not cross-react with native B subunit but strongly recognized denatured forms of the protein. Finally, the monoclonal antibody 13C4 was shown to bind to a discontinuous epitope expressed only on the native form of the protein. These immunological reagents can be used to probe the conformational state of the B subunit and the holotoxin as it relates to their functional properties.

This article has been cited by other articles:

• De Rosa, M. F., Ackerley, C., Wang, B., Ito, S., Clarke, D. M., Lingwood, C. (2008). Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog. J. Biol. Chem. 283: 4501-4511 [Abstract] [Full Text]  
• Smith, M. J., Carvalho, H. M., Melton-Celsa, A. R., O'Brien, A. D. (2006). The 13C4 Monoclonal Antibody That Neutralizes Shiga Toxin Type 1 (Stx1) Recognizes Three Regions on the Stx1 B Subunit and Prevents Stx1 from Binding to Its Eukaryotic Receptor Globotriaosylceramide. Infect. Immun. 74: 6992-6998 [Abstract] [Full Text]  
• Marcato, P., Griener, T. P., Mulvey, G. L., Armstrong, G. D. (2005). Recombinant Shiga Toxin B-Subunit-Keyhole Limpet Hemocyanin Conjugate Vaccine Protects Mice from Shigatoxemia. Infect. Immun. 73: 6523-6529 [Abstract] [Full Text]  
• Soltyk, A. M., MacKenzie, C. R., Wolski, V. M., Hirama, T., Kitov, P. I., Bundle, D. R., Brunton, J. L. (2002). A Mutational Analysis of the Globotriaosylceramide-binding Sites of Verotoxin VT1. J. Biol. Chem. 277: 5351-5359 [Abstract] [Full Text]  
• Wolski, V. M., Soltyk, A. M., Brunton, J. L. (2001). Mouse Toxicity and Cytokine Release by Verotoxin 1 B Subunit Mutants. Infect. Immun. 69: 579-583 [Abstract] [Full Text]  
• Nakao, H., Kiyokawa, N., Fujimoto, J., Yamasaki, S., Takeda, T. (1999). Monoclonal Antibody to Shiga Toxin 2 Which Blocks Receptor Binding and Neutralizes Cytotoxicity. Infect. Immun. 67: 5717-5722 [Abstract] [Full Text]  
• Paton, J. C., Paton, A. W. (1998). Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections. Clin. Microbiol. Rev. 11: 450-479 [Abstract] [Full Text]